USPTO 2015–2025 USPTO PatentsView US Corporation

Arcadia Biosciences, Inc.

USPTO PatentsView assignee record - 27 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES).

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

15.3

Avg claims per patent

+27%

5-year grant velocity

The verdict

According to USPTO PatentsView, Arcadia ranks #11,167 of 50,000 tracked US assignees by granted-patent volume, with 27 patents across 8 technology areas.

#11,167
of 50,000 US assignees by volume: Top 55%
by Innovation Score (33.8/100): 15.3
avg claims per patent: +27%
grant velocity, last 5 yrs

Portfolio overview

Arcadia Biosciences, Inc. has been granted 27 US utility patents between 2015 and 2025, placing Arcadia Biosciences, Inc. at #11,167 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.3 claims per patent with primary concentration in A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES). As a US Corporation, Arcadia Biosciences, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Arcadia sits between Alfmeier Präzision SE (27 patents, rank #11,151) and Addepar, Inc. (27 patents, rank #11,159) - the closest US assignees by grant volume. The composite Innovation Score of 33.8/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 14 grants, compared with 11 in the 2015–2019 window, a +27% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Arcadia Biosciences, Inc.'s 15.3 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 8 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Alfmeier PRÄZisio…

27
Anagog

27
Angus Chemical

27
Apollo Education…

27
Asahi Group Holdi…

27
ASSA Abloy Reside…

27
Adaptimmune

27
Addepar

27
Arcadia Bioscienc… ◀

27

What this shows Arcadia holds 27 patents at rank #11,155, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Arcadia

By rank, the assignees closest to #11,155 in granted patent volume.

Leaders in A01H (NEW Plants OR)

Other assignees with the most granted patents in Arcadia's primary technology class.

Arcadia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 Top 55% higher than 45% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Arcadia Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	7.4%
2016	3	11.1%
2018	1	3.7%
2019	5	18.5%
2020	5	18.5%
2021	3	11.1%
2022	1	3.7%
2023	3	11.1%
2024	2	7.4%
2025partial year	2	7.4%

Which technologies does Arcadia Biosciences, Inc. patent most?

A01H - NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES 27

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 22

C12Y - ENZYMES 16

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 13

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 10

C07K - PEPTIDES 7

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 6

A21D - TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS 3

Top 8 of 8 technology areas

Grant record at a glance

Portfolio Volume 27 grants

CPC subclasses 8

Avg. claims / grant 15.3

Velocity +27%

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#11,167

of 50,000 tracked assignees

Innovation Score

33.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does Arcadia Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Arcadia Biosciences, Inc. ranks #11,167 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Arcadia Biosciences, Inc. hold?

Arcadia Biosciences, Inc. holds 27 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Arcadia Biosciences, Inc.'s Innovation Score?

Arcadia Biosciences, Inc. has an Innovation Score of 33.8 out of 100 (top 55% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Arcadia Biosciences, Inc. focus on?

Arcadia Biosciences, Inc.'s top technology area is A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES) with 27 patents. Grants appear in 8 CPC subclasses total.

Is Arcadia Biosciences, Inc.'s patent grant rate increasing or decreasing?

Arcadia Biosciences, Inc.'s recent grant velocity is +27% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Arcadia Biosciences, Inc.'s patents?

Arcadia Biosciences, Inc.'s patents average 15.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Arcadia Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Arcadia's 27 grants land it in the top 55% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Arcadia ranks #11,167 of 50,000. Top 50 holders
Most of this portfolio concentrates in A01H - see who else leads that technology area. A01H leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.